SUBSCRIBERS
Shanghai Pharma buys Cardinal Health's China business for US$557m
Published Wed, Nov 15, 2017 · 09:50 PM
Hong Kong
SHANGHAI Pharmaceuticals Holding Co has agreed to buy Cardinal Health Inc's China drug distribution business for US$557 million, winning a highly competitive auction in a move that will greatly expand its presence nationwide.
The deal will also help Shanghai Pharma, China's third largest drug distributor, become a leading importer of foreign medicine into the world's second largest drug market.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
IndoAgri appoints former EDB chairman Philip Yeo as chairman and lead independent director
GSK profit drops 23% in Q1 on higher costs
Starbucks points to weaker consumer as profit falls
Restaurant Brands tops estimates as Burger King overhaul pays off
Walmart to shut all health centers in US over lack of profitability
Coca-Cola raises annual sales forecast on global demand, higher prices